2023
DOI: 10.3390/jcm13010150
|View full text |Cite
|
Sign up to set email alerts
|

Myocarditis and Chronic Inflammatory Cardiomyopathy, from Acute Inflammation to Chronic Inflammatory Damage: An Update on Pathophysiology and Diagnosis

Giuseppe Uccello,
Giacomo Bonacchi,
Valentina Alice Rossi
et al.

Abstract: Acute myocarditis covers a wide spectrum of clinical presentations, from uncomplicated myocarditis to severe forms complicated by hemodynamic instability and ventricular arrhythmias; however, all these forms are characterized by acute myocardial inflammation. The term “chronic inflammatory cardiomyopathy” describes a persistent/chronic inflammatory condition with a clinical phenotype of dilated and/or hypokinetic cardiomyopathy associated with symptoms of heart failure and increased risk for arrhythmias. A con… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 131 publications
(181 reference statements)
0
0
0
Order By: Relevance
“…Myocarditis can have a variety of clinical manifestations such as chest pain, new or worsening heart failure, chronic heart failure, life-threatening hemodynamic compromise (i.e., fulminant myocarditis, with cardiogenic shock and severely reduced LVEF), life-threatening arrhythmias, or conduction disturbances [ 15 ]. Diagnostic tools used when myocarditis is suspected include cardiac MRI, which has the highest sensitivity if performed two to three weeks after the initial clinical presentation, endomyocardial biopsy, which remains the gold-standard technique to diagnose acute myocarditis [ 16 ] and reveals an inflammatory infiltrate with necrosis or degeneration of adjacent myocytes, markers of myocyte injury and inflammation such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) although not specific and not necessarily increased in myocarditis, high sensitivity troponins, brain natriuretic peptide (BNP) and NT-proBNP (useful but not specific) [ 15 ]. Ten months after the initial presentation, the patient presented with new-onset heart failure in the setting of fluid overload with failed peritoneal dialysis two months prior (eight months after the initial presentation).…”
Section: Discussionmentioning
confidence: 99%
“…Myocarditis can have a variety of clinical manifestations such as chest pain, new or worsening heart failure, chronic heart failure, life-threatening hemodynamic compromise (i.e., fulminant myocarditis, with cardiogenic shock and severely reduced LVEF), life-threatening arrhythmias, or conduction disturbances [ 15 ]. Diagnostic tools used when myocarditis is suspected include cardiac MRI, which has the highest sensitivity if performed two to three weeks after the initial clinical presentation, endomyocardial biopsy, which remains the gold-standard technique to diagnose acute myocarditis [ 16 ] and reveals an inflammatory infiltrate with necrosis or degeneration of adjacent myocytes, markers of myocyte injury and inflammation such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) although not specific and not necessarily increased in myocarditis, high sensitivity troponins, brain natriuretic peptide (BNP) and NT-proBNP (useful but not specific) [ 15 ]. Ten months after the initial presentation, the patient presented with new-onset heart failure in the setting of fluid overload with failed peritoneal dialysis two months prior (eight months after the initial presentation).…”
Section: Discussionmentioning
confidence: 99%